Findings

What do systematic reviews say?

541 questions · 556 findings · 112 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 130 · 23.4%GRADE not reported 22 · 4%Very low 156 · 28.1%Low 151 · 27.2%Moderate 72 · 12.9%High 25 · 4.5%

Balloon (Foley or ATAD) vs low‐dose oral misoprostol

Admission to neonatal intensive care unit · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with low‐dose oral misoprostol (low certainty).

1 finding from 1 review

Mechanical methods for induction of labour 2023 · Cochrane Headline outcomes only
RR 0.82 [0.58, 1.17]
5 studies · 2873 participants
Low

Balloon (Foley or ATAD) vs vaginal prostaglandin E2

Admission to neonatal intensive care unit · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with vaginal prostaglandin E2 (low certainty).

1 finding from 1 review

Mechanical methods for induction of labour 2023 · Cochrane Headline outcomes only
RR 0.82 [0.65, 1.04]
12 studies · 3647 participants
Low

HFNC vs low flow nasal cannula (LFNC)

ICU length of stay (selenium) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))

1 finding from 1 review

High flow nasal cannula for respiratory support in term infants 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 74 participants
Very low

HFNC vs continuous positive airway pressure (CPAP)

ICU length of stay (general intensive care patients) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))

1 finding from 1 review

High flow nasal cannula for respiratory support in term infants 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 452 participants
Moderate

Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids vs single course

Admission to the intensive care unit ‐ not reported · the woman

The review found no eligible studies for this question.

1 finding from 1 review

Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Routine vaginal examination vs routine rectal examination

Admission to neonatal intensive care unit · pregnant women in labour at term

It is very uncertain whether routine vaginal examination changes admission to neonatal intensive care unit№ of participants: 307(1 RCT) compared with routine rectal examination (very low certainty).

1 finding from 1 review

Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women… 2022 · Cochrane Headline outcomes only
RR 1.32 [0.47, 3.73]
Studies not reported
Very low

Etanercept vs no etanercept

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cyclosporin vs no cyclosporin

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IVIg vs corticosteroids

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etanercept vs corticosteroids

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Corticosteroids vs no corticosteroid use

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cyclosporin vs corticosteroids

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etanercept vs intravenous immunoglobulin (IVIG)

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cyclosporin vs intravenous immunoglobulin (IVIG)

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etanercept vs cyclosporin

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IVIg vs no IVIG

Duration of ICU stay · Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

PCC vs FVIIa

Length of critical care stay (hours) · cardiac surgery for the treatment of non‐surgical bleeding

1 finding from 1 review

Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Very low

PCC vs usual care

Length of critical care stay (hours) · cardiac surgery for the treatment of non‐surgical bleeding

1 finding from 1 review

Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 151 participants
Moderate

Distress tolerance training vs control

Smoking cessation · people who smoke

Distress tolerance training showed no clear difference in distress tolerance training vs less intensive smoking cessation… compared with control (low certainty).

1 finding from 1 review

Mindfulness for smoking cessation 2022 · Cochrane Headline outcomes only
RR 1.63 [0.33, 8.08]
1 study · 49 participants
Low

Mindfulness vs control

Smoking cessation · people who smoke

It is very uncertain whether mindfulness training changes mindfulness training vs less intensive smoking cessation treatment:… compared with control (very low certainty).

1 finding from 1 review

Mindfulness for smoking cessation 2022 · Cochrane Headline outcomes only
RR 1.19 [0.65, 2.19]
5 studies · 813 participants
Very low